Santa Clara, CA--(Marketwire - August 14, 2008) - Symyx Technologies, Inc. (NASDAQ: SMMX), today announced it has acquired Camarillo, CA-based Integrity Biosolution, LLC in an all-cash transaction. IntegrityBio is a leader in contract formulation research and analytical services, providing high-quality, cost-effective formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.
